首页> 外文OA文献 >Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil

【2h】

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil

机译：与多西紫杉醇，顺铂和5-氟尿嘧啶的同时进行化学疗法，与顺铂和5-氟尿嘧啶的常规同步化学疗法相比，改善了食管癌晚期食管癌的患者的存活

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yukihisa Tamaki; Yoko Hieda; Masanobu Nakajima; Kazuhiro Kitajima; Rika Yoshida; Takeshi Yoshizako; Atsushi Ue; Mutsumi Tokudo; Noriyuki Hirahara; Ichiro Moriyama; Hiroyuki Kato; Taisuke Inomata;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil [J] . Yukihisa Tamaki, Yoko Hieda, Masanobu Nakajima, Journal of Cancer . 2018,第16期

机译：与传统的同时顺铂和5-氟尿嘧啶同时放化疗相比，多西他赛，顺铂和5-氟尿嘧啶同时放化疗可提高晚期食管癌患者的生存率
2. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer [J] . Haisley K. R., Hart K. D., Nabavizadeh N., Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus . 2017,第7期

机译：与同时顺铂/ 5-氟尿嘧啶的Neoadjuvant ChemorAdiotapy acky与患有当地晚期食管癌的患者的Carboplatin / Parlitaxel相比有关的病理完全反应增加和提高存活
3. Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine|[sol]|cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer |[ndash]| a multi-centre randomised phase II study [J] . R Wilkowski, S Boeck, S Ostermaier, British Journal of Cancer . 2009,第11期

机译：并发吉西他滨和顺铂联合或不联合吉西他滨| [sol] |顺铂的放化疗与放疗联合5-氟尿嘧啶的局部放化疗| [ndash] |多中心随机II期研究
4. Laryngo-pharyngeal function after concurrent chemoradiotherapy in patients with laryngeal cancer or hypopharyngeal cancer. [C] . Furukawa Madoka K., Kubota A., Yagi H., World Congress for Bronchology . 2011

机译：喉切咽喉咽喉咽喉咽喉疗法患者喉癌或白血病患者后喉咽咽。
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Concurrent Chemoradiotherapy with Docetaxel Cisplatin and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil [O] . Yukihisa Tamaki, Yoko Hieda, Masanobu Nakajima, 2018

机译：与传统的顺铂和5-氟尿嘧啶同时放化疗相比多西他赛顺铂和5-氟尿嘧啶同时放化疗可提高晚期食管癌患者的生存率
7. Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study [O] . Wilkowski, R, Boeck, S, Ostermaier, S, 2009

机译：局部晚期胰腺癌患者中同时吉西他滨和顺铂联合或不联合吉西他滨/顺铂联合化学放化疗与5-氟尿嘧啶同时化疗的放化疗–多中心随机II期研究

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil

著录项

相似文献

相关主题

期刊订阅